Transmedics Grp logo

Transmedics Grp Stock

StockStock
ISIN: US89377M1099
Ticker: TMDX
US89377M1099
TMDX

Price

Frequently asked questions

What is Transmedics Grp's market capitalization?

The market capitalization of Transmedics Grp is $2.75B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Transmedics Grp's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Transmedics Grp is 87.31. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Transmedics Grp?

Transmedics Grp's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.939. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Transmedics Grp's stock?

Currently, 9 analysts cover Transmedics Grp's stock, with a consensus target price of $136.14. Analyst ratings provide insights into the stock's expected performance.

What is Transmedics Grp's revenue over the trailing twelve months?

Over the trailing twelve months, Transmedics Grp reported a revenue of $401.09M.

What is the EBITDA for Transmedics Grp?

Transmedics Grp's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $49.16M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Transmedics Grp?

Transmedics Grp has a free cash flow of -$120.51M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Transmedics Grp's stock?

The 5-year beta for Transmedics Grp is 2.07. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Transmedics Grp have, and what sector and industry does it belong to?

Transmedics Grp employs approximately 584 people. It operates in the Health Care sector, specifically within the Medical Equipment & Supplies industry.

What is the free float of Transmedics Grp's shares?

The free float of Transmedics Grp is 32.50M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 
$2.75B

5Y beta

 
2.07

EPS (TTM)

 
$0.939

Free Float

 
32.50M

P/E ratio (TTM)

 
87.31

Revenue (TTM)

 
$401.09M

EBITDA (TTM)

 
$49.16M

Free Cashflow (TTM)

 
-$120.51M

Pricing

1D span
$82.15$83.40
52W span
$40.01$177.37

Analyst Ratings

The price target is $136.14 and the stock is covered by 9 analysts.

Buy

8

Hold

1

Sell

0

Information

TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside of the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ retrieval, OCS organ management and logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation, ground transportation and other coordination activity. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.

584

Medical Equipment & Supplies

Health Care

Identifier

ISIN

US89377M1099

Primary Ticker

TMDX

Knockouts

Join the conversation